Vori Health Secures $53 Million Funding for Musculoskeletal Care Expansion

Vori Health has successfully raised $53 million in a Series B funding round, led by New Enterprise Associates (NEA) with participation from several other investors. The company, which focuses on innovative musculoskeletal care, reported significant clinical outcomes, including a 91.6% rate of pain improvement and substantial reductions in elective orthopedic surgeries and opioid use. This funding will allow Vori Health to enhance its value-based care model, expand its AI technology platform, and strengthen partnerships with national employers and health plans. The company aims to address the fragmented nature of musculoskeletal care in the U.S. by integrating virtual and in-person services with a team of health professionals. Vori Health has experienced rapid growth, achieving an 800% increase in revenue over the past 18 months, indicating strong market demand for its comprehensive solutions. CEO Dr. Ryan Grant emphasized that this investment marks a pivotal moment in their mission to deliver value-based care at scale.